Transaction #6407 · Form 4 · 0001193125-25-274369

Enova International, Inc. · Stock award · Non-Qualified Stock Option (right to buy) with limited SAR

Enova International, Inc. · Transacted November 6, 2025 · Filed November 10, 2025

Original SEC filing ↗

What does this filing report?

An SEC Form 4 filing for Enova International, Inc. records a stock award involving Non-Qualified Stock Option (right to buy) with limited SAR on November 6, 2025. The reported quantity was 20,793. The filing date is November 10, 2025. This is one transaction record; amounts are not allocated among any joint reporting owners.

The acquisition category describes how securities were received. It does not by itself establish a cash purchase of common stock. Read the transaction code definitionsand the original filing before interpreting the amounts.

Transaction details

Company CIK
0001529864
Security type
Derivative
Acquisition type
Stock award · Code A
Quantity acquired
20,793
Reported price
0
Reference value
0
Currency
Currency not specified
Ownership
Direct
Holdings after transaction
20,793
Ownership description
Not reported
SEC acceptance time
Nov 10, 2025, 4:30 PM EST
10b5-1 indication
Not indicated

Reference value is reported quantity × reported price. It is not a confirmed cash payment or an estimate of a derivative's economic value. A missing currency is not assumed to be USD.

Reporting owners

These are the reporting owners named in the filing. Quantities and amounts are not allocated among co-reporters. Roles reflect this filing, not a current profile.

Company listings

ENVA · NYSE

This transaction is not mapped to a specific company listing.

Derivative terms

Underlying security
Common stock; par value $0.00001 per share
Underlying quantity
20,793
Conversion / exercise price
128
Exercise date
Not reported
Expiration date
November 6, 2032

Filing footnotes & remarks

F1
The limited stock appreciation right ("SAR") and employee stock option were granted in tandem. Accordingly, the exercise of one results in the expiration of the other. The SAR may be exercised only during the period beginning on the first day following the date that a "Change in Control" of Issuer occurs (as defined in the related grant agreement) and ending on the thirtieth day following such date. Upon exercise, the grantee shall be able to receive an amount equal to the product computed by multiplying (i) the excess of the "Offer Value Per Share" over the exercise price of the underlying option by (ii) the number of shares with respect to which the SAR is being exercised; provided, that such amount shall only be payable in the event an "Offer" is made.
F2
The "Offer Value Per Share" means the average selling price of Issuer's common stock during the period of 30 days ending on the date on which the SAR is exercised. "Offer" means any tender offer or exchange offer for outstanding shares of Issuer representing at least 30% of the total voting power of the stock of Issuer, or an offer to purchase assets from Issuer that have a total gross fair market value equal to or more than 40% of the total gross fair market value of all of the assets of Issuer, other than an offer made by Issuer.
F3
The options shall vest in substantially equal one-third increments on each of the following dates as long as grantee serves as an employee of Issuer or an affiliate thereof through the applicable vesting date: November 6, 2026, November 6, 2027 and November 6, 2028.

Footnotes are reproduced as plain text from the current source filing. For the full context, read the original SEC filing.

This record was updated Eastern Time. This is the stored record update time, not the transaction date. Report a correction.